Navigation Links
Pwo DNA Polymerase

for routine high fidelity amplification of up to 3.5 kb DNA targets Cat. No. 1 664 947 100 units
Cat. No. 1 664 955 2 x 250 units Description Pwo DNA polymerase was originally isolated from hyperthermophilic archaebacterium Pyrococcus woesei. The enzyme has a molecular weight of about 90 kD. It is a highly processive 5'3' DNA polymerase and possesses an 3'5' exonuclease activity also known as proofreading activity. The enzyme has no detectable 5'3' exonuclease activity. Pwo DNA polymerase exhibits increased thermal stability with a half life of greater than 2 h at 100C compared to Taq DNA polymerase with a half life of less than 5 min at this temperature. The inherent 3'5' exonuclease proofreading activity Pwo results in an over 18-fold increased fidelity of DNA synthesis compared to Taq DNA polymerase. Pwo DNA polymerase generated PCR products are blunt-ended and can therefore be used directly for blunt-end ligation without any pretreatment of the ends. For further information please download the Pwo DNA Polymerase
pack insert
. Application Fidelity of in vitro DNA polymerization is one of the most important subjects in PCR. For many applications of PCR, where a homogenous DNA population is analyzed (i.e. direct sequencing or restriction endonu-clease digestion), the mutations that are induced by the polymerase during PCR are of little concern. However if only a small amount of template DNA or RNA is used as starting mat erial and if after PCR single DNA molecules are analyzed, PCR artifacts can be a significant problem. Fidelity of DNA polymerization is for instance important for:
  • cloning of PCR products
  • study of allelic polymorphism in individual RNA transcripts (1, 2)
  • characterisation of the allelic stage of single cells (3) or single DNA molecules (4, 5)
  • characterisation of rare mutations in tissue (6)
  • characterisation of a population of cells in culture
Operating parameters
  • Thermal stability: Pwo DNA Polymerase is stable for >2 h at 95C
  • Divalent ion requirement: Mg2+ (standard concentration, 2.00 mM)
  • dNTP concentration: at least 200 M for each dNTP
    Caution: Lower deoxynucleotide concentrations can increase fidelity but can also activate the 3'5' exonuclease proofreading activity, which might degrade prime
Experimental results Key advantages
  • Maximum PCR fidelity, because the proofreading activity of Pwo DNA Polymerase excises misincorporated nucleotides
  • High PCR yield, because the polymerase is very resistant to the high denaturing temperatures used in PCR
  • Simplifies cloning of PCR products because it generates blunt-ended products which can be directly used f or blunt-end ligation
Note: Pwo DNA Polymerase cannot amplify targets longer than approx. 3.5 kb. For high fidelity amplification of longer templates use one of the Expand PCR Systems.
'"/>

Source:


Page: All 1 2 3

Related biology technology :

1. Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase
2. Pfu DNA Polymerase as a Hot Start Alternative
3. PCR Performance Comparisons Between pfuturbo and Taq DNA Polymerases
4. pfuturbo DNA Polymerase: A High-Performance, High-Fidelity Enzyme Ideal for PCR Cloning
5. Unique DNA Polymerase Formulation Excels in a Broad Range of PCR Applications
6. Enhanced Amplification of Long Targets with PfuTurbo DNA Polymerase
7. High-Fidelity PCR with a Novel Polymerase Mixture
8. Optimizing pfuturbo DNA Polymerase Amplification Reactions with Perfect Match PCR Enhancer
9. Unique Enhanced DNA Polymerase Delivers High Fidelity and Great PCR Performance
10. The Use of MasterTaq Polymerase for PCR with Humic Material-Contaminated DNA
11. HotStarTaq DNA Polymerase
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/11/2016)... Biosciences, Inc. (NASDAQ: NBIX ) today announced its financial results ... --> --> For the fourth quarter ... or $0.34 loss per share, compared to a net loss of ... in 2014. For the year ended December 31, 2015, the Company ... share, as compared to a net loss of $60.5 million, or ...
(Date:2/11/2016)... and GERMANTOWN, Maryland , ... Frankfurt Prime Standard: QIA) today announced the introduction of ... gene expression profiling, expanding QIAGEN,s portfolio of Sample to ... researchers to select from over 20,000 human genes and ... between genes, cellular phenotypes and disease processes. --> ...
(Date:2/11/2016)... Feb. 11, 2016  Spectra BioPharma Selling Solutions (Spectra) ... provides biopharma companies the experience, expertise, operational delivery ... outsourced sales teams. Created in concert with industry ... the strategic and tactical needs of its clients ... through both personal and non-personal promotion. ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... to delivering cutting-edge information focused on the development and manufacture of biopharmaceuticals ... a premier sponsor of the 2016 BioProcess International Awards – Recognizing Excellence ...
Breaking Biology Technology:
(Date:2/2/2016)... MOUNTAIN VIEW, Calif. , Feb. 2, 2016 ... diabetic retinopathy market, Frost & Sullivan recognizes US-based ... North America Frost & Sullivan Award for New ... technology provider in North America ... standard in the rapidly growing diabetic retinopathy market. ...
(Date:1/28/2016)... SYNA ), a leading developer of human interface solutions, today ... --> --> Net revenue ... to the comparable quarter last year to $470.5 million. Net income ... $0.93 per diluted share. --> ... 2016 grew 9 percent over the prior year period to $60.3 ...
(Date:1/22/2016)... , January 22, 2016 /PRNewswire/ ... announced the addition of the  "Global ... their offering. --> http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ... the  "Global Behavioral Biometric Market 2016-2020" ... Research and Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) ...
Breaking Biology News(10 mins):